Literature DB >> 1882761

Prominent dural enhancement adjacent to nonmeningiomatous malignant lesions on contrast-enhanced MR images.

G Wilms1, M Lammens, G Marchal, P Demaerel, J Verplancke, F Van Calenbergh, J Goffin, C Plets, A L Baert.   

Abstract

Prominent dural enhancement was noted in 10 (16%) of 61 superficial malignant intracranial tumors studied with contrast-enhanced MR imaging during a 2-year period. Included were six glioblastomas, three parenchymal metastases, and one case of dural metastasis. Seven patients had surgery. In four, there was extensive leptomeningeal invasion in the center of the lesion. In two of these lesions there was firm attachment of the center of the tumor to the dura, but without dural invasion despite extensive external carotid artery supply to the tumor in one case. In two cases the overlying dura was normal, and there was no leptomeningeal tumoral invasion. In the case of dural metastasis, huge nodular lesions were present along the inner aspect of the dura. In none of the cases did prominent dural enhancement adjacent to the tumor correspond with tumoral invasion or extension to the dura. Prominent dural enhancement on contrast-enhanced MR images appears to be much less frequent in malignant tumor than in meningioma, where it is seen in up to 60% of the cases. We believe this finding is more likely to represent reactive changes of the dura than tumoral invasion.

Entities:  

Mesh:

Year:  1991        PMID: 1882761      PMCID: PMC8331606     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  13 in total

1.  A review on dural tail sign.

Authors:  Houman Sotoudeh; Hadi Rokni Yazdi
Journal:  World J Radiol       Date:  2010-05-28

2.  Dural-based lesions: is it a meningioma?

Authors:  Vitor Nagai Yamaki; Luis Filipe de Souza Godoy; Gabriela Alencar Bandeira; Leandro Tavares Lucato; Gustavo Correa Lordelo; Davi Jorge Fontoura Solla; Iuri Santana Neville; Manoel Jacobsen Teixeira; Wellingson Silva Paiva
Journal:  Neuroradiology       Date:  2021-01-18       Impact factor: 2.804

3.  Medulloblastoma presenting with tentorial "dural-tail" sign: is the "dural-tail" sign specific for meningioma?

Authors:  P W Detwiler; J S Henn; R W Porter; M T Lawton; W L White; R F Spetzler
Journal:  Skull Base Surg       Date:  1998

Review 4.  Diagnostic challenges in meningioma.

Authors:  Martha Nowosielski; Norbert Galldiks; Sarah Iglseder; Philipp Kickingereder; Andreas von Deimling; Martin Bendszus; Wolfgang Wick; Felix Sahm
Journal:  Neuro Oncol       Date:  2017-11-29       Impact factor: 12.300

5.  Frequency and Evolution of New Postoperative Enhancement on 3 Tesla Intraoperative and Early Postoperative Magnetic Resonance Imaging.

Authors:  Nityanand Miskin; Prashin Unadkat; Michael E Carlton; Alexandra J Golby; Geoffrey S Young; Raymond Y Huang
Journal:  Neurosurgery       Date:  2020-08-01       Impact factor: 4.654

6.  Dural enhancement with primary calvarial lesions.

Authors:  E Arana; L Martí-Bonmatí; V Ricart; M Pérez-Ebrí
Journal:  Neuroradiology       Date:  2004-11-06       Impact factor: 2.804

7.  Gliosarcoma of the posterior cranial fossa: MRI findings.

Authors:  H Nitta; H Hayase; Y Moriyama; T Yamashima; J Yamashita
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804

8.  Metastatic breast carcinoma mimicking basal skull meningioma.

Authors:  Gregory W Schmidt; Neil R Miller
Journal:  Clin Ophthalmol       Date:  2007-09

9.  Contribution of dynamic contrast MR imaging to the differentiation between dural metastasis and meningioma.

Authors:  S Kremer; S Grand; C Rémy; B Pasquier; A L Benabid; S Bracard; J F Le Bas
Journal:  Neuroradiology       Date:  2004-06-30       Impact factor: 2.804

10.  Prevalence of and Factors Associated with Dural Thickness in Patients with Mild Cognitive Impairment and Alzheimer's Disease.

Authors:  Adnan I Qureshi; Iryna Lobanova; Naseeb Ullah; Amna Sohail; Taqi A Zafar; Adil M Malik; Mushtaq H Qureshi
Journal:  J Vasc Interv Neurol       Date:  2015-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.